WASHINGTON, April  19, 2023 (BSS/AFP) - The US Supreme Court was poised
Wednesday to wade into the divisive battle over the abortion drug mifepristone
with a ruling on tough new court-ordered restrictions on the widely used pill.

The nation's highest court has until midnight Eastern Time (0400 GMT
Thursday) to decide how it will handle the most significant abortion case since
it tossed out the constitutional right to the procedure last year.

The panel can rule in any number of ways, and abortion rights and
anti-abortion activists -- as well as millions of Americans -- are on
tenterhooks waiting to see how the conservative-dominated court proceeds in the
latest case involving women's reproductive rights.

The case stems from a ruling this month by a US District Court judge in
Texas that would have banned mifepristone, which was approved by the Food and
Drug Administration in 2000 and accounts for more than half of all abortions in
the United States.

An appeals court blocked a ban on the pill, but imposed tough restrictions
on access, after which the baton was handed to the Supreme Court.

The Supreme Court, where conservatives wield a 6-3 majority, on Friday
temporarily stayed the lower court rulings as it weighs what to do next.

The Supreme Court could decide to freeze the lower court rulings pending an
appeal from the Justice Department and the mifepristone manufacturer Danco
Laboratories.

It could also allow the rulings restricting access to the abortion pill to
take effect while the appeals play out at the appellate level.

The court could also decide to hear arguments in the case itself on an
expedited basis.

Complicating the case even further is a ruling by a separate federal court
in Washington state that said access to mifepristone should be maintained.

Since the Supreme Court overturned the landmark Roe v. Wade ruling that
enshrined the constitutional right to abortion for half a century, 13 states
have banned abortion and it has been severely restricted in others.

- 'Clear choice' -

Democratic Representative Katherine Clark said Wednesday that the court
faces a "clear choice."

"Uphold legal and scientific fact or capitulate to MAGA extremism," Clark
said in a reference to former Republican president Donald Trump's "Make America
Great Again" slogan.

"This case marks just the latest assault in the MAGA crusade on
reproductive freedom," Clark told reporters. "Republicans have one goal -- a
nationwide abortion ban."

Opposition to the legal attack on the abortion pill is being spearheaded by
the Justice Department, which argued that the initial conservative federal
judge's ruling was based on a "deeply misguided assessment" of the pill's
safety.

Mifepristone is one component of a two-drug regimen that can be used
through the first 10 weeks of pregnancy. It has a long safety record, and the
FDA estimates 5.6 million Americans have used it to terminate pregnancies since
it was approved.

The appellate court, while striking down the ban on mifepristone,
restricted its use to seven weeks of pregnancy, down from 10, and prohibited
distribution by mail.

In a filing to the court on Tuesday, the anti-abortion coalition that first
brought the case against the FDA repeated their controversial claims that the
drug was unsafe.

The coalition said the FDA and the distributor of mifepristone had
"brazenly flouted the law and applicable regulations ... and continually placed
politics above women's health."

Polls repeatedly show a clear majority of Americans support continued
access to safe abortion, even as conservative groups push to limit the
procedure -- or ban it outright.